Upcoming events

Renal denervation

Here you will find all the latest content on renal denervation published on this website. Results are listed in chronological order.

Despite the existence of effective antihypertensive drugs, arterial hypertension remains a critical challenge for healthcare systems worldwide. Can catheter-based renal denervation play an effective part in reducing, previously untreatable high blood pressure? Follow the latest research in this novel field along with the critical issues of blood pressure monitoring, imaging modalities, tools, devices and techniques as well as vascular access, bleeding risk and adjunctive pharmacotherapy…

Filtered By
Renal denervation

70 results

Renal denervation - Current challenges and perspectives

Renal denervation, a hot topic several years ago, but where is it today? We join K. Tsioufis and T. Zeller to learn about the surprising developments in renal denervation that hold a promise for a clinical future. What are the new and emerging strategies being employed? Are their new devices? How are new imaging modalities affecting the approach to the renal artery? What is the nature of the ongoing studies? Do we understand more about patient selections and, finally, will renal denervation take its place as an effective therapy in treating resistant hypertensive patients? Learn more here …

Alcohol-mediated endovascular renal denervation

From EuroPCR 2016

Hotline refractory hypertension! EuroPCR 2016 focused on the emerging and creatively diverse clinical techniques and accompanying data we are beginning to see in the realm of renal denervation. More and more focused on specific anatomies and patient selection, join W. Wojakowski as he walks us through a renal denervation procedure involving the safe introduction by injection of absolute alcohol to the peri-vascular area of the renal artery…what did he see? Watch and find out!

Renal denervation for hypertension treatment: what has happened in 2015 and where to go next?

What lessons did we learn about hypertension in 2015? A. Pathak, F. Mahfoud and K. Tsioufis explore recent and ongoing trials in the treatment of hypertension: Are the guidelines changing? How is our understanding of the agents used in first-line treatment of resistant hypertension evolving? For interventional cardiologists, what are the emerging evidence concerning renal denervation that will cast light on its further use, such as a more profound understanding of renal nerve fibres? How will this affect your practice today and in the future? Join us!

New insights in renal denervation

19 May 2016 – From EuroPCR 2016

Roland Schmieder

Chairperson

Roland Schmieder

Resistant hypertension management

18 May 2016 – From EuroPCR 2016

Dr. Felix Mahfoud

Chairperson

Felix Mahfoud
Flavio Ribichini

Chairperson

Flavio Ribichini

Catheter-based renal denervation exchange forum around the globe: building the future By and For your experience

18 May 2016 – From EuroPCR 2016

Critical appraisal of devices for the management of hypertension

18 May 2016 – From EuroPCR 2016

Dr. Felix Mahfoud

Chairperson

Felix Mahfoud
Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher

What's new in hypertension? An update for interventionists

17 May 2016 – From EuroPCR 2016

Renal and peripheral interventions

17 May 2016 – From EuroPCR 2016

Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher
Dr. Felix Mahfoud

Chairperson

Felix Mahfoud

Mid- and long-term outcome after renal denervation

17 May 2016 – From EuroPCR 2016

Chairperson

Faisal Sharif